Literature DB >> 30426885

The Development and Reliability of 4 Clinical Neurocognitive Single-Leg Hop Tests: Implications for Return to Activity Decision-Making.

Nathan Millikan, Dustin R Grooms, Brett Hoffman, Janet E Simon.   

Abstract

Context: Functional tests are limited primarily by measuring only physical performance. However, athletes often multitask, and deal with complex visual-spatial processing while being engaged in physical activity. Objective: To present the development and reliability of 4 new neurocognitive single-leg hop tests that provide more ecological validity to test sport activity demands than previous functional return to sport testing. Design: Cross-sectional. Setting: Gymnasium. Participants: Twenty-two healthy participants (9 males and 13 females; 20.9 [2.5] y, 171.2 [11.7] cm, 70.3 [11.0] kg) were recruited. Interventions: Maximum distance (physical performance) and reaction time (cognitive performance) were measured for 3 of the neurocognitive hop tests all testing a different aspect of neurocognition (single-leg central-reaction hop-reaction time to 1 central stimulus, single-leg peripheral-reaction crossover hop-reaction time between 2 peripheral stimuli, and single-leg memory triple hop-reaction to memorized stimulus with distractor stimuli). Fastest time (physical performance) and reaction time (cognitive performance) were measured for the fourth neurocognitive hop test (single-leg pursuit 6m hop-requiring visual field tracking [pursuit] and spatial navigation). Main Outcome Measures: Intraclass correlation coefficients were calculated to assess reliability of the 4 new hop tests. Additionally, Bland-Altman plots and 1-sample t tests were conducted for each single-leg neurocognitive hop to evaluate any systematic changes.
Results: Intraclass correlation coefficients based on day 1 and day 2 scores ranged from .87 to .98 for both legs for physical and cognitive performance. The Bland-Altman plots and 1-sample t tests (P > .05) indicated that all 4 single-leg neurocognitive hop tests did not change systematically. Conclusions: These data provide evidence that a neurocognitive component can be added to the traditional single-leg hop tests to provide a more ecologically valid test that incorporates the integration of physical and cognitive function for return to sport. The test-retest reliability of the 4 new neurocognitive hop tests is highly reliable and does not change systematically.

Entities:  

Keywords:  FitLight; cognitive; functional performance; visuomotor

Mesh:

Year:  2019        PMID: 30426885     DOI: 10.1123/jsr.2018-0037

Source DB:  PubMed          Journal:  J Sport Rehabil        ISSN: 1056-6716            Impact factor:   1.931


  5 in total

Review 1.  Which Functional Tests and Self-Reported Questionnaires Can Help Clinicians Make Valid Return to Sport Decisions in Patients With Chronic Ankle Instability? A Narrative Review and Expert Opinion.

Authors:  Brice Picot; Alexandre Hardy; Romain Terrier; Bruno Tassignon; Ronny Lopes; François Fourchet
Journal:  Front Sports Act Living       Date:  2022-05-26

2.  INCORPORATING A DUAL-TASK ASSESSMENT PROTOCOL WITH FUNCTIONAL HOP TESTING.

Authors:  Brandon M Ness; Kory Zimney; Thomas Kernozek; William E Schweinle; Amy Schweinle
Journal:  Int J Sports Phys Ther       Date:  2020-05

Review 3.  Anterior cruciate ligament injury mechanisms through a neurocognition lens: implications for injury screening.

Authors:  Alli Gokeler; Anne Benjaminse; Francesco Della Villa; Fillippo Tosarelli; Evert Verhagen; Jochen Baumeister
Journal:  BMJ Open Sport Exerc Med       Date:  2021-05-17

4.  Test-retest reliability of a smartphone app for measuring core stability for two dynamic exercises.

Authors:  Paloma Guillén-Rogel; Cristina Franco-Escudero; Pedro J Marín
Journal:  PeerJ       Date:  2019-08-09       Impact factor: 2.984

5.  A Compound Hop Index for Assessing Soccer Players' Performance.

Authors:  Łukasz Oleksy; Aleksandra Królikowska; Anna Mika; Maciej Kuchciak; Daniel Szymczyk; Marian Rzepko; Grzegorz Bril; Robert Prill; Artur Stolarczyk; Paweł Reichert
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.